Enhancing Cancer Treatment with Hypoxic Breathing
Author Information
Author(s): A.I. Minchinton, J.M. Brown
Primary Institution: Stanford University Medical Center
Hypothesis
Can hypoxic breathing enhance the effectiveness of the cytotoxic agent SR 4233 in treating tumors?
Conclusion
Hypoxic breathing significantly increases the antitumor effectiveness of SR 4233 when used in fractionated radiation therapy.
Supporting Evidence
- The combination of SR 4233 and hypoxic breathing resulted in a 10-fold increase in antitumor effectiveness.
- Hypoxic breathing increased the systemic toxicity of SR 4233.
- Mathematical modeling predicted enhanced effectiveness of SR 4233 with hypoxic breathing.
- The study showed that hypoxic cells in tumors are a major obstacle to effective radiation therapy.
Takeaway
Breathing in less oxygen can help a cancer drug work better against tumors, but it can also make the treatment more toxic.
Methodology
Mice were treated with SR 4233 and exposed to a hypoxic environment after radiation therapy to assess tumor response.
Potential Biases
Potential bias in the selection of treatment protocols and animal models.
Limitations
The study primarily involved animal models, which may not fully represent human responses.
Participant Demographics
Male and female C3H/Km mice were used in the study.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% confidence limits 2.82-14.76
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website